Description
RETA 30mg contains retatrutide, an investigational compound that acts across GLP-1, GIP and glucagon receptor pathways.
Current research is examining retatrutide in relation to appetite regulation, energy balance, glucose metabolism and broader metabolic processes. Retatrutide is not approved for routine therapeutic use.
Research notice: For laboratory and scientific research purposes only. Not intended for human or veterinary consumption, diagnosis, treatment or therapeutic use.
Reviews
There are no reviews yet.